Home > Insider Trading > Filing (0000899243-20-016780)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1501134	Invitae Corp	NVTA	Services-Medical Laboratories (8071)	271701898

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1689575	Katherine Stueland	C/O Invitae Corporation 1400 16Th Street San Francisco CA 94103	Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-06-12	1,000	$16.34	203,925	No	4	S	Direct
Common Stock	Acquisiton	2020-06-12	59,150	$0.00	263,075	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	A	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Acquisiton	2020-06-12	19,600	$0.00	19,600	$16.17

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
19,600		2030-06-12	No	4	A	Direct

Footnotes

These sales of common stock were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 22, 2019.
Includes an aggregate of 154,490 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
Shares issuable upon settlement of a restricted stock unit award that vests in three equal installments, with 1/3rd of the total award vesting on each of June 12, 2021, 2022 and 2023.
Includes an aggregate of 213,640 shares of common stock issuable pursuant to restricted stock units that have not vested.
Option vests over four years, with 25% of the shares vesting on June 12, 2021, and 1/48th of the remaining shares vesting monthly thereafter for the remaining three years.